Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadeja Urbanic Purkart

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|September 10, 2020
Vitamin D and Hyperkinetic Movement Disorders: A Systematic ReviewCarl N Homann, Gerd Ivanic, Barbara Homann, et al.
Journal of Neuro-Oncology|September 8, 2022
miR-497 and 219 in blood aid meningioma classificationAhmed Abdelrahman, Caterina Negroni, Felix Sahm, et al.
Journal of Neurology|November 5, 2015
Poor short-term outcome in patients with ischaemic stroke and active cancerMarkus Kneihsl, Christian Enzinger, Gerit Wünsch, et al.
Iscience|July 21, 2025
Prevalence and risk factors for asymptomatic venous thromboembolism in patients with primary brain tumorsViktoria Nemecz, Reinhard B Raggam, Tadeja Urbanic-Purkart, et al.
International Journal of Radiation Oncology, Biology, Physics|November 12, 2025
Patient-Reported Outcomes, Neurocognitive Functioning, and Oncologic Results of Pencil-Beam-Scanning Proton Beam Therapy for CNS WHO G2 and G3 IDH1-Mutant Diffuse Adult Glioma: A Single Institution ExperienceMaciej J Pelak, Allan Hummer, Eugen Hug, et al.
JAMA|October 1, 2014
Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trialKarin Amrein, Christian Schnedl, Alexander Holl, et al.
Cancers|March 25, 2022
MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based ImmunotherapyJohanna Heugenhauser, Malik Galijasevic, Stephanie Mangesius, et al.
Neuro-Oncology Advances|May 12, 2025
Personalized targeted glioblastoma therapies by ex vivo drug screening: Study protocol of the Advanced brain Tumor TheRApy Clinical Trial (ATTRACT)Anna Sophie Berghoff, Maximilian J Mair, Zoltán Spiró, et al.
Neuro-Oncology Practice|August 7, 2019
Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma NetworkAmélie Darlix, Emmanuel Mandonnet, Christian F Freyschlag, et al.
Journal of Neuro-Oncology|August 27, 2024
Glioblastoma in the real-world setting: patterns of care and outcome in the Austrian populationAndreas Hainfellner, Martin Borkovec, Lukas Seebrecht, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|September 10, 2020
Vitamin D and Hyperkinetic Movement Disorders: A Systematic ReviewCarl N Homann, Gerd Ivanic, Barbara Homann, et al.
Journal of Neuro-Oncology|September 8, 2022
miR-497 and 219 in blood aid meningioma classificationAhmed Abdelrahman, Caterina Negroni, Felix Sahm, et al.
Journal of Neurology|November 5, 2015
Poor short-term outcome in patients with ischaemic stroke and active cancerMarkus Kneihsl, Christian Enzinger, Gerit Wünsch, et al.
Iscience|July 21, 2025
Prevalence and risk factors for asymptomatic venous thromboembolism in patients with primary brain tumorsViktoria Nemecz, Reinhard B Raggam, Tadeja Urbanic-Purkart, et al.
International Journal of Radiation Oncology, Biology, Physics|November 12, 2025
Patient-Reported Outcomes, Neurocognitive Functioning, and Oncologic Results of Pencil-Beam-Scanning Proton Beam Therapy for CNS WHO G2 and G3 IDH1-Mutant Diffuse Adult Glioma: A Single Institution ExperienceMaciej J Pelak, Allan Hummer, Eugen Hug, et al.
JAMA|October 1, 2014
Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trialKarin Amrein, Christian Schnedl, Alexander Holl, et al.
Cancers|March 25, 2022
MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based ImmunotherapyJohanna Heugenhauser, Malik Galijasevic, Stephanie Mangesius, et al.
Neuro-Oncology Advances|May 12, 2025
Personalized targeted glioblastoma therapies by ex vivo drug screening: Study protocol of the Advanced brain Tumor TheRApy Clinical Trial (ATTRACT)Anna Sophie Berghoff, Maximilian J Mair, Zoltán Spiró, et al.
Neuro-Oncology Practice|August 7, 2019
Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma NetworkAmélie Darlix, Emmanuel Mandonnet, Christian F Freyschlag, et al.
Journal of Neuro-Oncology|August 27, 2024
Glioblastoma in the real-world setting: patterns of care and outcome in the Austrian populationAndreas Hainfellner, Martin Borkovec, Lukas Seebrecht, et al.
Pageof 2